Pulsed intense light to treat dry eye syndrome
1 Ophthalmologist, Natal Eye Clinic, Natal - RN, Brazil.
2 Undergraduate Student of Medicine at UnP - Potiguar University - Laureate International Universities – Natal/Brazil
3 Postgraduate Program in Biotechnology at Potiguar University/ UnP - Laureate International Universities – Natal/Brazil. Ph.D. in Health Science.
Review Article
GSC Biological and Pharmaceutical Sciences, 2019, 09(03), 035-040.
Article DOI: 10.30574/gscbps.2019.9.3.0221
Publication history:
Received on 23 November 2019; revised on 03 December 2019; accepted on 04 December 2019
Abstract:
Intense Pulsed Light (IPL) is the therapeutic tool implemented in the treatment of dry eye, characterized by the emission of waves of 500-1200nm in the region of the upper and lower eyelids. Dry eye is a recurring complaint in ophthalmology offices and has an impact on the patient's quality of life. It results from dysfunction of the meibomian glands, duct obstruction, and quantitative and qualitative changes in glandular secretion. It is manifested by dryness and irritation, foreign body sensation, burning, tearing, and eye fatigue. The available treatments are short term palliative with unsatisfactory results. To determine through a literature review, the benefit of using intense pulsed light for dry eye treatment. Methodology: We searched the Cochrane database, PubMed, Embase, Scopus, Web of Science, and Google Scholar (gray literature) using the keywords for an independent, blinded, peer-reviewed selection of articles to be met following pre-established criteria. Studies evaluated the use of IPL in patients with dry eye, despite the benefit found, focus on the objective and subjective assessment of the eye more frequently. Evidence-based clinical guidelines are required for the use of intense pulsed light in the treatment of Meibomian Gland Dysfunction (MGD), as well as a device and algorithm for indications of therapeutic use.
Keywords:
Dry eye syndromes; Intense pulsed light therapy; Meibomian glands; Tarsal gland; Phototherapy; Eye diseases
Full text article in PDF:
Copyright information:
Copyright © 2019 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
